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Abstract
Background: The enzyme glucose-6-phosphatase catalyzes the dephosphorylation of glucose-6-
phosphatase to glucose, the final step in the gluconeogenic and glycogenolytic pathways. Expression
of the glucose-6-phosphatase gene is induced by glucocorticoids and elevated levels of intracellular
cAMP. The effect of cAMP in regulating glucose-6-phosphatase gene transcription was
corroborated by the identification of two genetic motifs CRE1 and CRE2 in the human and murine
glucose-6-phosphatase gene promoter that resemble cAMP response elements (CRE).
Results: The cAMP response element is a point of convergence for many extracellular and
intracellular signals, including cAMP, calcium, and neurotrophins. The major CRE binding protein
CREB, a member of the basic region leucine zipper (bZIP) family of transcription factors, requires
phosphorylation to become a biologically active transcriptional activator. Since unphosphorylated
CREB is transcriptionally silent simple overexpression studies cannot be performed to test the
biological role of CRE-like sequences of the glucose-6-phosphatase gene. The use of a constitutively
active CREB2/CREB fusion protein allowed us to uncouple the investigation of target genes of
CREB from the variety of signaling pathways that lead to an activation of CREB. Here, we show
that this constitutively active CREB2/CREB fusion protein strikingly enhanced reporter gene
transcription mediated by either CRE1 or CRE2 derived from the glucose-6-phosphatase gene.
Likewise, reporter gene transcription was enhanced following expression of the catalytic subunit
of cAMP-dependent protein kinase (PKA) in the nucleus of transfected cells. In contrast, activating
transcription factor 2 (ATF2), known to compete with CREB for binding to the canonical CRE
sequence 5'-TGACGTCA-3', did not transactivate reporter genes containing CRE1, CRE2, or both
CREs derived from the glucose-6-phosphatase gene.
Conclusions: Using a constitutively active CREB2/CREB fusion protein and a mutant of the PKA
catalytic subunit that is targeted to the nucleus, we have shown that the glucose-6-phosphatase
gene has two distinct genetic elements that function as bona fide CRE. This study further shows that
the expression vectors encoding C2/CREB and catalytic subunit of PKA are valuable tools for the
study of CREB-mediated gene transcription and the biological functions of CREB.
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Background
The glucose-6-phosphatase system consists of the glucose-
6-phosphate catalytic subunit (EC 3.1.3.9), embedded in
the membrane of the endoplasmic reticulum (ER) via
nine transmembrane domains, and the membrane span-
ning translocases, responsible in carrying either the sub-
strate into the ER or the product from the ER [1].
Transport of substrate and product is necessary due to the
orientation of the active site of the glucose-6-phosphatase
enzyme towards the luminal side of the ER. Glucose-6-
phosphate, the end product of both gluconeogenesis and
glycogenolysis in the liver, is hydrolyzed by the glucose-6-
phosphatase system allowing the liberation of glucose
into the circulation. Thus, glucose-6-phosphatase plays a
key role in the homeostasis of blood glucose. Mutations
in the gene encoding the catalytic subunit of glucose-6-
phosphatase are responsible for the development of gly-
cogen storage disease type 1, also known as Gierke disease
[2]. In animal models of diabetes mellitus, glucose-6-
phosphatase activity is increased along with mRNA and
protein levels [3]. Accordingly, inhibitors of glucose-6-
phosphatase or the G6PT transporter are used for the
treatment of type 2 diabetes.
The glucose-6-phosphatase encoding gene is regulated by
a variety of extracellular signaling molecules, including
glucose, insulin, glucocorticoids, and cAMP. Insulin
decreases the level of glucose-6-phosphatase mRNA in the
liver and in hepatoma cells and three functionally distinct
insulin response elements have been identified [4]. Glu-
cocorticoids elevate glucose-6-phosphatase promoter
activity mediated by a glucocorticoid response element
and hepatocyte nuclear factor 1 [5]. Conflicting results
were published concerning the stimulation of glucose-6-
phosphatase promoter activity by elevated intracellular
cAMP concentrations. While dibutyryl cAMP alone did
not significantly stimulate transcription of a luciferase
reporter gene under control of 1.2 kb of the human glu-
cose-6-phosphatase promoter in H4IIIE hepatoma cells
[6], a later report by the same group described a ≈ 2-fold
stimulation of glucose-6-phosphatase promoter activity
with dibutyryl cAMP [7]. The sequence from -161 to -152
of the human glucose-6-phosphatase promoter, including
the motif 5'-TTTACGTAA-3', was proposed to mediate the
effect of dibutyryl cAMP on reporter gene transcription
[7]. In HepG2 cells a glucose-6-phosphatase promoter/
chloramphenicol acetyltransferase reporter gene showed a
2 to 3-fold enhancement in transcription following stim-
ulation of the cells with dibutyryl cAMP [8]. Here, the
sequence from -136 to -129 of the human glucose-6-phos-
phatase gene, including the motif 5'-TTGCATCAA-3', was
proposed to be essential to couple dibutyryl cAMP stimu-
lation with enhanced reporter gene transcription [8].
The most important and best characterized protein that
connects an elevation of intracellular cAMP concentra-
tions with enhanced transcription of selected genes is the
CRE binding protein CREB, a basic region leucine zipper
protein. CREB plays an essential role in the regulation of
glucose-6-phosphatase gene transcription in the liver, as
exemplified by the fact that transgenic mice expressing a
dominant-negative CREB mutant in the liver show
reduced mRNA levels of glucose-6-phosphatase [9]. CREB
not only mediates stimulus-transcription coupling of the
cAMP signaling pathway but functions as a point of con-
vergence of many other signaling molecules involving cal-
cium, neurotrophins, tumor promoters, and growth
factors [10]. CREB is inactive in the dephosphorylated
state and turns into an activator upon phosphorylation.
The key enzyme leading to CREB activation is the cAMP-
dependent protein kinase (PKA), but CREB serves also as
a substrate for calcium/calmodulin-dependent protein
kinase IV and the mitogen-and stress-activated kinases
MSK1 and 2 [11,12]. To study CREB regulated gene tran-
scription, a signaling cascade needs to be activated that
leads to phosphorylation and activation of CREB. This can
be accomplished by adding cAMP analogues such as dib-
utyryl cAMP that passes the plasma membrane or via a
direct activation of adenylate cyclase by forskolin. This
experimental setting is problematic in that high levels of
phosphodiesterase enzymes in the cells may immediately
hydrolyze cAMP, with the result that no cAMP-mediated
gene transcription can be monitored [13]. Moreover, ele-
vated levels of cAMP may additionally activate the EPAC/
Rap1 pathway, making it somewhat difficult to attribute
the effect of cAMP solely to the cAMP/PKA signaling path-
way. Many functions of cAMP previously attributed to
PKA may be in fact the result of EPAC activation [14].
Instead of increasing the intracellular levels of cAMP some
investigators employed an overexpression strategy using
the catalytic subunit of cAMP-dependent protein kinase to
analyze cAMP regulated genes. This approach has the
advantage that by excluding a parallel signaling cascade
via the cAMP-inducible nucleotide exchange factor EPAC,
only the biological outcome of cAMP-dependent protein
kinase activation is studied. However, the translocation of
the catalytic subunit of cAMP-dependent protein kinase
into the nucleus is not very efficient and may rely solely
on diffusion [15]. Thus high amounts of expression vector
in the range of 1 to 5 µg/plate are often transfected [16-18]
in order to observe an effect on gene transcription. Natu-
rally, these high amounts of expressed catalytic subunit
are far away from the physiological concentrations within
the cells.
Here, we report on the regulation of glucose-6-phos-
phatase gene transcription by CREB and PKA. Using a con-
stitutively active CREB2/CREB fusion protein, that doesBMC Molecular Biology 2005, 6:2 http://www.biomedcentral.com/1471-2199/6/2
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not require phosphorylation for activation, and a nuclear-
targeted mutant of the catalytic subunit of PKA, we show
that CREB activates transcription of glucose-6-phos-
phatase promoter/luciferase reporter genes via two dis-
tinct genetic elements. In contrast, the bZIP protein ATF2,
known to compete with CREB for binding to the canoni-
cal CRE, did not transactivate these reporter genes con-
taining CRE1, CRE2, or both CREs derived from the
glucose-6-phosphatase gene.
Results
The proximal region of the human glucose-6-phosphatase 
gene contains two cyclic AMP response element like motifs
Fig. 1A shows part of the proximal region of the human
glucose-6-phosphatase gene. As indicated, two CRE-like
sequences are present, resembling the canonical CRE
sequence 5'-TGACGTCA-3'. The distal CRE-like site
(CRE1) and the proximal CRE-like site (CRE2) differ on
two or three positions, respectively, in comparison to the
canonical CRE. To investigate the biological function of
these elements we constructed a battery of reporter plas-
mids containing both CRE-like elements or only one of
them (Fig. 1B,C). Mutations were introduced into CRE1
and CRE2 sites to prevent CREB binding [19]. As a con-
trol, we generated a reporter plasmid containing two cop-
ies of a CRE/AP1-like element derived from the human
tumor necrosis factor (TNF) α gene promoter (Fig. 1D).
The TNFα gene belongs to the target genes of CREB [10].
Additionally, the reporter genes contained a TATA box
derived from the HIV long terminal repeat, an initiator
element from the adenovirus major late promoter and the
luciferase open reading frame.
A constitutively active CREB2/CREB fusion protein 
transactivates reporter genes with either CRE1 or CRE2 of 
the glucose-6-phosphatase gene in their regulatory regions
The fact that unphosphorylated CREB is transcriptionally
silent excludes a simple overexpression strategy to analyze
the biological impact of the CRE-like sequences within the
glucose-6-phosphatase gene. The use of natural inducers
of CREB such as glucagon or epinephrine, that all elevate
the cAMP concentration in the cells, also triggers pleio-
tropic responses by activating the cAMP-dependent pro-
tein kinase and the EPAC/Rap1 pathway, so that the
biological outcome cannot be attributed solely to CREB
activation. We therefore designed a constitutively active
CREB2/CREB fusion protein to uncouple the investiga-
tion of glucose-6-phosphatase gene transcription from
signaling pathways in the cell. Fig. 2A shows the structural
domains of the basic region leucine zipper (bZIP) tran-
scription factors CREB and CREB2. Both proteins contain
a bZIP domain on their C-termini responsible for dimeri-
zation and DNA-binding. The N-termini of CREB and
CREB2 contain activation domains. While the activation
domain of CREB2 is constitutively active and transferable
to heterologous DNA-binding domains [20], the major
activation domain of CREB is controlled by phosphoryla-
tion. We expressed the bZIP domain of CREB, which is
responsible for DNA binding and dimerization, as a
fusion protein with the constitutively active transcrip-
tional activation domain of CREB2, generating the chi-
meric transcription factor C2/CREB (Fig. 2A). The C2/
CREB fusion protein contains additionally an immuno-
logical tag used for the detection of the protein. Proteins
derived from nuclear extracts of HepG2 human hepatoma
cells (mock) or HepG2 cells transfected with an expres-
sion vector encoding C2/CREB were fractionated by SDS-
PAGE. The fusion protein was identified by Western Blot
analysis using antibodies targeting the FLAG epitope. Fig.
2B shows that the CREB2/CREB fusion protein was syn-
thesized as expected.
To study the regulation of the glucose-6-phosphatase pro-
moter/luciferase reporter genes by C2/CREB, we decided
to use the human hepatoma cell line HepG2, as it has
been reported that activation of the cAMP signaling path-
way stimulates glucose-6-phosphatase gene transcription
in these cells [17,21,22]. HepG2 cells were transfected
with one of the luciferase reporter plasmids pG6PCRE1/
CRE2luc, pG6PCRE1mut/CRE2luc, pG6PCRE1/
CRE2mutluc, pG6PCRE1luc or pG6PCRE2luc together
with either the "empty" expression vector pCMV5
(denoted "-") or an expression vector encoding C2/CREB
(plasmid pCMV-FLAG-C2/CREB) (denoted "+"). As a
control, we transfected the pTNFα(CRE/AP1)2luc reporter
plasmid that contains two copies of the composite CRE/
AP1 element of the TNFα promoter. We transfected addi-
tionally plasmid pRSVβ, encoding β-galactosidase under
the control of the Rous sarcoma virus long-terminal
repeat, to correct for variations in transfection efficiencies.
Luciferase activities were normalized for transfection effi-
ciency by dividing luciferase light units by β-galactosidase
activities. The results of the transfection experiments are
depicted in Fig. 3. Transcription of the pG6PCRE1/
CRE2luc reporter gene, that contains both CRE-like
sequences in its regulatory region, was strongly induced
following expression of C2/CREB (Fig. 3A, upper panel).
Mutation of CRE1 or CRE2 did not abolish the transacti-
vation potential of C2/CREB (Fig. 3A, middle, bottom
panel), indicating that both CRE-like sequences function
independently as bona fide CREs. This conclusion was con-
firmed by transfection experiments of reporter plasmids
having only one of the CRE-like sequences in the regula-
tory regions. Fig. 3B shows that both reporter genes
pG6PCRE1luc and pG6PCRE2luc were transactivated by
C2/CREB. Finally, C2/CREB also transactivated the
pTNFα(CRE/AP1)2luc reporter gene via the CRE/AP1 ele-
ment (Fig. 3C). We conclude that both CRE1 and CRE2
motifs of the glucose-6-phosphatase gene promoter func-
tion as bona fide CREs.BMC Molecular Biology 2005, 6:2 http://www.biomedcentral.com/1471-2199/6/2
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The human glucose-6-phosphatase gene promoter Figure 1
The human glucose-6-phosphatase gene promoter. (A) Sequence of a portion of the human glucose-6-phosphatase 
gene promoter including the CRE-like sequences CRE1 and CRE2. (B) The reporter plasmid pG6PCRE1/CRE2luc contains a 
minimal promoter consisting of the human immunodeficiency virus TATA box, the adenovirus major late promoter initiator 
element, the luciferase open reading frame, and glucose-6-phosphatase promoter sequences encompassing both CRE-like 
sequences CRE1 and CRE2. The reporter plasmids pG6PCRE1mut/CRE2luc and pG6PCRE1/CRE2mutluc carry mutations in 
either the CRE1 or the CRE2, to inactivate these sites. (C) Reporter plasmids pG6PCRE1luc and pG6PCRE2luc contain glu-
cose-6-phosphatase promoter sequences encompassing either the CRE1 or the CRE2. (D) The reporter plasmid pTNFα(CRE/
AP1)2luc contains two identical copies of the composite CRE/AP1 sequence derived from the human TNFα gene, upstream of 
a minimal promoter. The sequence of one of these motifs is depicted.
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Expression of a nuclear-targeted catalytic subunit of 
cAMP-dependent protein kinase
The structural domains of the catalytic subunit of cAMP-
dependent protein kinase (ATP:protein phosphotrans-
ferase, EC 2.7.1.37) are depicted in Fig. 4A. The protein is
myristylated on the N-terminus, but myristylation is non-
essential for enzyme activation [23]. We modified the N-
terminal region of the protein by adding a nuclear target-
ing signal derived from the SV40 large T antigen (NLS)
and a FLAG epitope to facilitate immunological detection.
This mutant termed NLSCα should be sorted to the
nuclear compartment, due to the presence of the NLS.
HepG2 cells were transfected with an expression vector
encoding NLSCα. Nuclear extracts of these cells were frac-
tionated by SDS-PAGE and analyzed by Western blotting.
Fig. 4B shows that the modified catalytic subunit of cAMP-
dependent protein kinase was synthesized as expected.
To test the biological activity of NLSCα, in comparison to
the wild-type form of the catalytic subunit (Cα), we meas-
ured the activity of the phosphorylation-regulated tran-
scription factor CREB using a fusion protein consisting of
the GAL4 DNA-binding domain fused to the kinase
inducible activation domain of CREB. The modular struc-
ture of the GAL4-CREB fusion protein is depicted in Fig.
4C. Transcriptional activation was monitored by co-trans-
fection of the reporter plasmid pUAS5luc that contains
five copies of the GAL4 binding site termed "upstream
activating sequence" (UAS) upstream of a luciferase
reporter gene (Fig. 4C). Since mammalian cells do not
express transcription factors that bind to the UAS, this sys-
tem directly measures the effect of NLSCα or Cα on the
transcriptional activation potential of CREB. The reporter
plasmid pUAS5luc and the expression plasmid that
encodes GAL4-CREB were transfected into HepG2 cells
together with either an "empty" expression vector
(denoted "-") or expression vectors encoding Cα or
NLSCα. Transfection efficiency was monitored by co-
transfecting pRSVβ. As a control, plasmid pM1 encoding
only the DNA binding domain of GAL4 (GAL4DBD) was
transfected. Cell extracts were prepared forty-eight hours
later and β-galactosidase and luciferase activities were
determined. Fig. 4C shows that the modified form of PKA
catalytic subunit (NLSCα) was highly potent in stimulat-
ing the transcriptional activation potential of CREB. The
activation was on the order of 60-fold. In contrast, no
transcriptional activation was observed following overex-
pression of the wild-type form of the catalytic subunit.
Next, we tested the biological activity of NLSCα with
regard to transcription of the glucose-6-phosphatase pro-
moter/luciferase reporter genes. In the experiments, we
additionally overexpressed wild-type CREB, the
CREBS133A containing a serine to alanine mutation at
position 133, and K-CREB, a CREB mutant containing the
point mutation R286L within the basic DNA-binding
domain, impairing DNA-binding [24]. Transfection of
expression vectors encoding the wild-type form of CREB,
CREBS133A, or K-CREB did not significantly change basal
transcription of the reporter genes. However, transfection
of an NLSCα expression vector strongly stimulated tran-
scription of the glucose-6-phosphatase promoter/luci-
ferase reporter genes, containing both or one of the CRE-
Schematic representation and expression of the constitu- tively active CREB2/CREB fusion protein C2/CREB Figure 2
Schematic representation and expression of the con-
stitutively active CREB2/CREB fusion protein C2/
CREB. (A) Schematic representation of the modular struc-
ture of CREB, CREB2, and C2/CREB. The basic region leu-
cine zipper domain (bZIP) is indicated. The chimeric bZIP 
protein C2/CREB consists of the constitutively active tran-
scriptional activation domain of CREB2 and the bZIP domain 
of CREB, responsible for dimerization and DNA-binding. (B) 
Western Blot analysis of HepG2 cells transfected with an 
expression vector encoding C2/CREB. As a control, extracts 
from mock transfected HepG2 cells were analyzed. Western 
blots were probed with an antibody against the FLAG-tag.
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Biological activity of C2/CREB, a constitutively active CREB2/CREB fusion protein Figure 3
Biological activity of C2/CREB, a constitutively active CREB2/CREB fusion protein. One of the reporter plasmids 
pG6PCRE1/CRE2luc, pG6PCRE1mut/CRE2luc pG6PCRE1/CRE2mutluc (A), pG6PCRE1luc, pG6PCRE2luc (B), or 
pTNFα(CRE/AP1)2luc (C) (1 µg/plate) was transfected into HepG2 cells together with the pRSVβ internal standard plasmid (2 
µg/plate), encoding β-galactosidase under the control of the Rous sarcoma virus long terminal repeat, and either the "empty" 
expression vector pCMV5 or an expression vector encoding C2/CREB (20 ng plasmid/plate). The data are presented as the 
ratio of luciferase activity (light units) to β-galactosidase units (OD units) measured in the cell extracts. The mean +/- SD is 
depicted.
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like sequences of the glucose-6-phosphatase promoter
(Fig. 5A,B). These results confirm the previous observa-
tions, obtained via overexpression of C2/CREB, that both
CRE motifs of the glucose-6-phosphatase gene function as
independent genetic elements responsive to couple ele-
vated cAMP and PKA levels with enhanced glucose-6-
phosphatase gene transcription. Similarly, coexpression
of wild-type CREB and NLSCα stimulated reporter gene
Schematic representation and biological activity of the nuclear targeted mutant of the catalytic subunit of cAMP-dependent  protein kinase Figure 4
Schematic representation and biological activity of the nuclear targeted mutant of the catalytic subunit of 
cAMP-dependent protein kinase. (A) Schematic representation of the modular structure of the catalytic subunit of cAMP-
dependent protein kinase (Cα) and the mutant NLSCα. The wild-type enzyme is myristylated as indicated (Myr). The sequence 
of the nuclear localization signal derived from the SV40 large T antigen and the triple FLAG epitope in NLSCα are shown. (B) 
Western Blot analysis of HepG2 cells transfected with an expression vector encoding NLSCα. As a control, extracts from 
mock transfected HepG2 cells were analyzed. Western blots were probed with an antibody against the FLAG-tag. (C) Modular 
structure of the GAL4-CREB fusion protein. The protein consists of the DNA-binding domain of GAL4 (amino acids 1–147) 
and the activation domain of CREB (amino acids 1–281). The reporter plasmid pUAS5luc contains a transcription unit encom-
passing the luciferase open reading frame and a minimal promoter that consists of five copies of the upstream activating 
sequence (UAS), a TATA box derived from the HIV long terminal repeat and the initiator element from the adenovirus major 
late promoter. The reporter plasmid pUAS5luc (1 µg/plate) was transfected into HepG2 cells together with the pRSVβ internal 
standard plasmid (2 µg/plate) and either an expression vector encoding the DNA binding domain of GAL4 (plasmid pM1) or 
the GAL4-CREB fusion protein (1 µg plasmid/plate). In addition, cells were transfected with an expression vector encoding 
either the wild-type (Cα) or mutated (NLSCα) form of cAMP-dependent protein kinase (100 ng/plate). Forty-eight hours post-
transfection cell extracts were prepared and the β-galactosidase and luciferase activities of these extracts were determined.
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Transcriptional activity of CREB and CREB mutants in the presence of a nuclear targeted mutant of the catalytic subunit of  cAMP-dependent protein kinase Figure 5
Transcriptional activity of CREB and CREB mutants in the presence of a nuclear targeted mutant of the cata-
lytic subunit of cAMP-dependent protein kinase. One of the reporter plasmids pG6PCRE1/CRE2luc, pG6PCRE1mut/
CRE2luc pG6PCRE1/CRE2mutluc (A), pG6PCRE1luc, pG6PCRE2luc (B), or pTNFα(CRE/AP1)2luc (C) (1 µg/plate) was trans-
fected into HepG2 cells together with the pRSVβ internal standard plasmid (2 µg/plate) and the "empty" expression vector 
pCMV5 or an expression vector encoding either CREB, CREBS133A, or K-CREB (20 ng plasmid/plate). In addition, an expres-
sion vector encoding NLSCα (100 ng/plate) was transfected. Forty-eight hours post-transfection cell extracts were prepared 
and the β-galactosidase and luciferase activities of these extracts were determined. The data are presented as the ratio of luci-
ferase activity (light units) to β-galactosidase units (OD units) measured in the cell extracts. The mean +/- SD is depicted.
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transcription mediated by the CRE/AP1 element derived
from the TNFα gene (Fig. 5C). Surprisingly, we still
detected reporter gene activation following coexpression
of NLSCα with CREBS133A, lacking the major PKA phos-
phorylation site. Compared to the coexpression experi-
ments of NLSCα with the wild-type form of CREB, the
reduced activation of reporter gene transcription in coex-
pression experiments of NLSCα with CREBS133A indi-
cates that NLSCα catalyzed phosphorylation of serine
residue 133 of CREB is important for reporter gene tran-
scription. The fact that CREBS133A is still able to transac-
tivate the reporter genes following expression of NLSCα
suggests that NLSCα triggers further phosphorylation
reactions leading to enhanced transcription via the CRE-
like sequences within the glucose-6-phosphatase gene. In
contrast, expression of K-CREB is transcriptionally inac-
tive, in the presence or absence of NLSCα, indicating that
DNA-binding is a prerequisite for CREB and CREBS133A
to transactivate the reporter genes.
Biological activity of a constitutively active CREB2/ATF2 
fusion protein on glucose-6-phosphatase promoter/
luciferase reporter genes
The transcription factor ATF2, a substrate of stress-acti-
vated protein kinases, has been reported to bind to the
classical cAMP responsive element (CRE) 5'-TGACGTCA-
3' [25]. Recently, we confirmed this observation showing
that ATF2 and CREB compete for binding to the CRE of
the secretogranin II gene [26]. ATF2 was proposed to also
bind with high affinity to the related DNA target sequence
5'-TTACGTAA-3' [19], which is identical to the CRE1 of
the glucose-6-phosphatase gene promoter. We tested the
biological activity of ATF2 on reporter genes containing
sequences of the glucose-6-phosphatase promoter region.
As a control, we used a reporter gene containing two cop-
ies of the CRE/AP-1 element of the TNFα gene. ATF2 has
been shown to stimulate TNFα promoter activity [27]. The
unphosphorylated form of ATF2 is transcriptionally inac-
tive, due to an inhibitory intramolecular interaction
between the activation domain of ATF2 and the bZIP
domain of ATF2 [28]. We therefore expressed a constitu-
tively active CREB2/ATF2 fusion protein to investigate
whether ATF2 functions as a transactivator for reporter
genes containing the CRE1 and/or CRE2 sequences of the
glucose-6-phosphatase gene in the regulatory region. The
domain structure of this C2/ATF2 fusion protein is
depicted in Fig. 6A. HepG2 cells were transfected with one
of the reporter plasmids (pG6PCRE1/CRE2luc,
pG6PCRE1mut/CRE2luc, pG6PCRE1/CRE2mutluc,
pG6PCRE1luc, and pG6PCRE2luc), the internal standard
plasmid pRSVβ, and an expression vector encoding C2/
ATF2. As a control, we analyzed the reporter plasmid
pTNFα(CRE/AP1)2luc. The results show that C2/ATF2 was
unable to transactivate the reporter genes containing
CRE1, CRE2, or both CRE-like sequences derived from the
glucose-6-phosphatase gene in the regulatory region, indi-
cating that glucose-6-phosphatase gene transcription is
not regulated by ATF2 via the two CRE-like sequences. In
contrast, C2/ATF2 strongly activated transcription of the
pTNFα(CRE/AP1)2luc reporter gene, confirming that
TNFα gene transcription is regulated by ATF2.
Discussion
The gene encoding glucose-6-phosphatase is regulated by
increased levels of intracellular cAMP, but the regulatory
sites responsible for cAMP-induced gene transcription are
still a matter of controversy. The objective of this study
was to characterize the genetic elements that function as
cis-acting sites for transactivation by CREB and that also
respond to activated PKA in the nucleus. Two distinct
genetic elements had been suggested to couple enhanced
levels of cAMP and elevated PKA activity with increased
glucose-6-phosphatase gene transcription [8,17] and we
intended to clarify which of these elements is required for
transactivation of the glucose-6-phosphatase gene by
CREB.
The reason for the differences in the published reports
concerning cAMP-regulated glucose-6-phosphatase gene
transcription can be explained by the technical problems
that occurs following elevation of the intracellular cAMP
concentration, as outlined in the introduction section. To
solve these problems, we prefered to measure "transcrip-
tional activation" instead of "transcription factor/DNA-
binding" because although DNA-binding is required for a
subsequent transcriptional activation by CREB, an
enhanced binding activity of a transcription factor to
DNA, monitored by an in vitro binding assay, does not
necessarily prove an enhanced transcriptional activation
potential of this protein [29]. In addition, we expressed a
constitutively active CREB2/CREB fusion protein that was
highly active in transactivating CREB-responsive target
genes. Using this strategy we avoided the use of dibutyryl
cAMP or forskolin, that may trigger other biological
responses. Furthermore, only nanomolar levels of the
expression vector encoding C2/CREB were required to
show that both CRE-like sequences (CRE1 and CRE2)
within the glucose-6-phosphatase gene function as target
sites for an active CREB. Thus, both the reported genetic
elements, the sequence from -161 to -152 [7] and the
sequence from -136 to -129 [8] of the human glucose-6-
phosphatase promoter, mediated reporter gene transacti-
vation by CREB. The fact that the glucose-6-phosphatase
gene contains two distinct genetic elements for the regula-
tion by CREB is not surprising as multiple CREs have been
found in other genes encoding for instance ICER, MKP-1,
Nur77 or Egr-4 [30].
Using an overexpression strategy for the catalytic subunit
of PKA, it has been reported that PKA directly stimulatesBMC Molecular Biology 2005, 6:2 http://www.biomedcentral.com/1471-2199/6/2
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Biological activity of constitutively active ATF2 fusion protein towards glucose-6-phosphatase promoter-containing reporter  genes Figure 6
Biological activity of constitutively active ATF2 fusion protein towards glucose-6-phosphatase promoter-con-
taining reporter genes. (A) Schematic representation of the modular structure of C2/ATF2. This chimeric bZIP protein 
consists of the constitutively active transcriptional activation domain of CREB2 and the bZIP domain of ATF2, responsible for 
dimerization and DNA-binding. (B, C, D) HepG2 cells were transfected with one of the reporter plasmids pG6PCRE1/
CRE2luc, pG6PCRE1mut/CRE2luc pG6PCRE1/CRE2mutluc (B), pG6PCRE1luc, pG6PCRE2luc (C), or pTNFα(CRE/AP1)2luc 
(D), the pRSVβ internal reference plasmid, and either the "empty" expression vector pCMV5 or an expression vector encoding 
C2/ATF2 (100 ng expression plasmid/plate). Lysates were prepared forty-eight hours post-transfection and β-galactosidase and 
luciferase activities were measured. The mean +/- SD is depicted.
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reporter gene transcription under control of CRE1,
whereas CRE2 was unable to connect elevated PKA activ-
ity with enhanced CRE2-controlled reporter gene tran-
scription [17]. The authors concluded that only the CRE1,
but not the CRE2 functions as bona fide CRE [17]. In this
study a concentration of 5 µg of expression vector encod-
ing the catalytic subunit of PKA was used. In the past, we
also employed this overexpression strategy for the cata-
lytic subunit of PKA in the laboratory [29,31] and
observed that high levels of expression vectors are
required to monitor an effect on gene transcription. We
also observed that transcription of the reference gene
encoding β-galactosidase under control of the Rous sar-
coma virus long terminal repeat was changed following
overexpression of the catalytic subunit, although no CRE
has been mapped within this promoter/enhancer region.
This fact indicates that transfection of micromolar levels
of expression vectors encoding the catalytic subunit of
PKA disturbs the machinery of transcription and the data
obtained by this approach may not always depict the real
picture. Likewise, it has been known for many years that
expression of the strong transcriptional activator VP16
induces transcriptional repression within the cells, due to
squelching. In the study reported here, expression of a
modified catalytic subunit that had a nuclear targeting sig-
nal, activated reporter gene transcription very efficiently
following transfection of nanomolar amounts of the
expression vector. In fact, we used a 50-fold lower amount
of expression vector compared to the study by Streeper et
al. [17]. Transfection of nanomolar concentrations of an
expression plasmid encoding the wild-type catalytic subu-
nit of PKA did not show any effect on reporter gene tran-
scription. These experiments, involving an overexpression
of NLSCα, showed an enhanced transcription of reporter
g e n e s  h a v i n g  e i t h e r  a n  i n t a c t  C R E 1  o r  C R E 2  i n  i t s
regulatory region, indicating that both CRE1 and CRE2
functioned as bona fide CRE. We also observed an activa-
tion of glucose-6-phosphatase promoter/luciferase
reporter gene transcription following coexpression of
CREBS133A with NLSCα. Phosphorylation of the serine
133 residue of CREB is the predominant mechanism to
enhance the transcriptional activation potential of CREB
via recruitment of the coactivator CREB binding protein
(CBP) and its paralogue p300 to the promoter. Accord-
ingly, we observed a clear reduction of reporter gene tran-
scription in coexpression studies of NLSCα together with
CREBS133A instead of wild-type CREB. However, expres-
sion of CREBS133A still contributed to reporter gene tran-
scription in the presence of NLSCα, suggesting that either
other residues of CREBS133A or other promoter-bound
proteins involved in the regulation of CREB-mediated
transcription are phosphorylated. PKA can phosphorylate
CBP directly or other components of the transcriptional
machinery downstream from CREB [32,33]. Nonetheless,
the experiments confirmed that both CRE-like sequences
within the glucose-6-phosphatase gene function as
genetic elements to mediate transactivation via CREB.
In contrast to the expression experiments involving C2/
CREB, we did not detect an effect of C2/ATF2, a constitu-
tively active CREB2/ATF2 fusion protein, on glucose-6-
phosphatase promoter/luciferase reporter gene
transcription, despite the fact that the sequence 5'-TTACG-
TAA-3', which is identical to the CRE1 site of the glucose-
6-phosphatase promoter, has been shown to function as a
high affinity binding site for ATF2 in vitro [19]. This dis-
crepancy supports the view that transcriptional bioassays
and not in vitro DNA-protein binding experiments
describe the biological activities of transcription factors.
The CRE-like sequences CRE1 and CRE2 of the glucose-6-
phosphatase gene are therefore strikingly different from
the CRE/AP1 site of the TNFα gene, that is strongly acti-
vated by C2/ATF2. Recently, we showed that ATF2 is able
to specifically transactivate CRE-containing genes and we
identified the secretogranin II gene as a target gene for
ATF2 [26]. We also showed that C2/ATF2 only marginally
enhanced transcription of a reporter gene carrying four
copies of the c-Fos CRE in its regulatory region, while tran-
scription regulated by the tyrosine hydroxylase promoter
was not upregulated at all. Thus, ATF2 distinguishs
between different CRE-containing genes. The biological
activity of ATF2 is regulated by stress-activated protein
kinases and ATF2 is thought to play an important role in
the cellular stress response. Our data sheds light on the
fact that expression of glucose-6-phosphatase is not con-
nected – via ATF2 – to the cellular stress response, in con-
trast to the TNFα gene.
Conclusions
We have shown that there are two distinct CREB-respon-
sive sites in the glucose-6-phosphatase gene promoter that
are responding to either a constitutively active CREB or
elevated concentrations of the catalytic subunit of cAMP-
dependent protein kinase in the nucleus. This study fur-
ther shows that the expression vectors encoding C2/CREB
and NLSCα are valuable tools for the investigation of
CREB-mediated gene transcription and the biological
functions of CREB. CREB is a key molecule in neuronal
survival, as demonstrated by the fact that a dominant-neg-
ative A-CREB induced apoptosis in sympathetic neurons
grown in NGF [34]. The C2/CREB fusion protein, that
directs CREB-mediated gene transcription in the absence
of PKA activation, can be used in gain-of-function experi-
ments to investigate the cytoprotective activity of CREB on
the molecular level. Most importantly, the C2/CREB pro-
tein can be used to identify anti-apoptotic genes that are
controlled by CREB. Likewise, expression of NLSCα will
permit the analysis of PKA-regulated gene transcription,
without influencing other functions of PKA in the cytosol.BMC Molecular Biology 2005, 6:2 http://www.biomedcentral.com/1471-2199/6/2
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Methods
Reporter constructs
The glucose-6-phosphatase promoter/luciferase reporter
genes pG6PCRE1/CRE2luc, pG6PCRE1mut/CRE2luc,
and pG6PCRE1/CRE2mutluc were constructed by the
insertion of the annealed oligonucleotides depicted in Fig.
1B with KpnI/XhoI cohesive ends into the KpnI/XhoI sites
of plasmid pHIVTATAluc [35]. The glucose-6-phos-
phatase promoter/luciferase reporter genes pG6PCRE1luc
and pG6PCRE2luc that contain either the CRE1 or the
CRE2 sequence derived from the human glucose-6-phos-
phatase gene were constructed by the insertion of the
annealed oligonucleotides depicted in Fig. 1C with XhoI/
SalI cohesive ends into the XhoI/SalI sites of plasmid
pHIVTATA-CAT [36]. These plasmids termed
pG6PCRE1CAT and pG6PCRE2CAT were digested with
XbaI, filled in with the Klenow fragment of DNA polymer-
ase I, recut with XhoI and cloned into plasmid pGL3-Basic
(Promega). The reporter gene pTNFα(CRE/AP-1)2luc, that
contains two copies of the CRE/AP1 element of the
human tumor necrosis factor α gene, was generated in a
similar way with annealed oligonucleotides encompass-
ing the sequence depicted in Fig. 1D. Plasmid pUAS5luc
containing the luciferase reporter gene, a TATA box
derived from the HIV long terminal repeat, an initiator
element from the adenovirus major late promoter, and
five binding sites for GAL4 (termed 'upstream activating
sequence', UAS) has been described [35].
Expression vectors
The expression vector pCMV-FLAG-C2/CREB, encoding a
constitutively active CREB2/CREB chimera, has been
described [26]. The CREB2/CREB fusion protein consists
of the amino-terminal 187 amino acids from CREB2,
encompassing the phosphorylation-independent tran-
scriptional activation domain, and amino acids 182 to
326 of CREB, including the bZIP domain. Expression vec-
tors encoding CREB, CREBS133A, and K-CREB were kind
gifts of Wilhart Knepel and Elke Oetjen, Department of
Molecular Pharmacology, University of Göttingen, Ger-
many. The expression vector encoding a constitutively
active CREB2/ATF2 fusion protein termed C2/ATF2 has
been described [27]. The GAL4 expression plasmid
pFA2CREB was purchased from Stratagene. The fusion
protein encodes the transcriptional activation sequence of
CREB (amino acids 1–281) fused to the DNA-binding
domain of GAL4. An expression vector encoding the cata-
lytic subunit of PKA (pCMVCα) was a kind gift of Michael
Uhler from the University of Michigan, Ann Arbor [37].
The construction of the NLSCα encoding expression
vector has been described [26]. NLSCα has a triple FLAG-
tag and a nuclear localization signal on the N-terminus,
followed by amino acids 19 to 351 of Cα. The expression
vector pRSVβ, encoding β-galactosidase under the control
of the Rous sarcoma virus long terminal repeat, has been
described [29].
Cell culture, transfections, and reporter gene assays
Human HepG2 hepatoma cells were cultured and trans-
fected as described [38]. The amounts of expression vec-
tors transfected are indicated in the figure legends. The
luciferase reporter plasmids (1 µg) and the internal refer-
ence plasmid pRSVβ were transfected into cells grown on
60 mm plates. Lysates were prepared forty-eight hours
later using cell culture lysis buffer (Promega) and β-galac-
tosidase and luciferase activities were measured as
described [35].
Western Blots
Nuclear extracts were prepared as described [39]. 20 µg of
nuclear proteins were separated by SDS-PAGE and the
blot was incubated with the M2 monoclonal antibody
directed against the FLAG epitope (Sigma, # F3165). Blots
were developed with a horseradish peroxidase conjugated
anti-mouse secondary antibody and ECL (Amersham,
Freiburg, Germany).
Abbreviations
ATF activating transcription factor
bZIP basic region leucine zipper
CRE cAMP response element
CREB cAMP response element binding protein
G6P glucose-6-phosphatase
PKA protein kinase A
TNF tumor necrosis factor
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